These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 33901495)

  • 41. Thioredoxin-interacting protein (Txnip) gene expression: sensing oxidative phosphorylation status and glycolytic rate.
    Yu FX; Chai TF; He H; Hagen T; Luo Y
    J Biol Chem; 2010 Aug; 285(33):25822-30. PubMed ID: 20558747
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice.
    Wong SH; Zhao L; Zhang X; Nakatsu G; Han J; Xu W; Xiao X; Kwong TNY; Tsoi H; Wu WKK; Zeng B; Chan FKL; Sung JJY; Wei H; Yu J
    Gastroenterology; 2017 Dec; 153(6):1621-1633.e6. PubMed ID: 28823860
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MUC1-mediated Macrophage Activation Promotes Colitis-associated Colorectal Cancer via Activating the Interleukin-6/ Signal Transducer and Activator of Transcription 3 Axis.
    Sheng YH; Davies JM; Wang R; Wong KY; Giri R; Yang Y; Begun J; Florin TH; Hasnain SZ; McGuckin MA
    Cell Mol Gastroenterol Hepatol; 2022; 14(4):789-811. PubMed ID: 35809803
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypoxia-inducible factor independent down-regulation of thioredoxin-interacting protein in hypoxia.
    Chai TF; Leck YC; He H; Yu FX; Luo Y; Hagen T
    FEBS Lett; 2011 Feb; 585(3):492-8. PubMed ID: 21192937
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer.
    Liu C; Liu R; Wang B; Lian J; Yao Y; Sun H; Zhang C; Fang L; Guan X; Shi J; Han S; Zhan F; Luo S; Yao Y; Zheng T; Zhang Y
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462141
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interferon-dependent IL-10 production by Tregs limits tumor Th17 inflammation.
    Stewart CA; Metheny H; Iida N; Smith L; Hanson M; Steinhagen F; Leighty RM; Roers A; Karp CL; Müller W; Trinchieri G
    J Clin Invest; 2013 Nov; 123(11):4859-74. PubMed ID: 24216477
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Instability of Helios-deficient Tregs is associated with conversion to a T-effector phenotype and enhanced antitumor immunity.
    Nakagawa H; Sido JM; Reyes EE; Kiers V; Cantor H; Kim HJ
    Proc Natl Acad Sci U S A; 2016 May; 113(22):6248-53. PubMed ID: 27185917
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bcl6 Preserves the Suppressive Function of Regulatory T Cells During Tumorigenesis.
    Li Y; Wang Z; Lin H; Wang L; Chen X; Liu Q; Zuo Q; Hu J; Wang H; Guo J; Xie L; Tang J; Li Z; Hu L; Xu L; Zhou X; Ye L; Huang Q; Xu L
    Front Immunol; 2020; 11():806. PubMed ID: 32477338
    [TBL] [Abstract][Full Text] [Related]  

  • 49. T cell subsets and colorectal cancer: discerning the good from the bad.
    Scurr M; Gallimore A; Godkin A
    Cell Immunol; 2012 Sep; 279(1):21-4. PubMed ID: 23041206
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dynamics of T-cell infiltration during the course of ovarian cancer: the gradual shift from a Th17 effector cell response to a predominant infiltration by regulatory T-cells.
    Fialová A; Partlová S; Sojka L; Hromádková H; Brtnický T; Fučíková J; Kocián P; Rob L; Bartůňková J; Spíšek R
    Int J Cancer; 2013 Mar; 132(5):1070-9. PubMed ID: 22865582
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Type I IFN gene delivery suppresses regulatory T cells within tumors.
    Hashimoto H; Ueda R; Narumi K; Heike Y; Yoshida T; Aoki K
    Cancer Gene Ther; 2014 Dec; 21(12):532-41. PubMed ID: 25430879
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Knockout of Factor-Inhibiting HIF (
    Schützhold V; Gravemeyer J; Bicker A; Hager T; Padberg C; Schäfer J; Wrobeln A; Steinbrink M; Zeynel S; Hankeln T; Becker JC; Fandrey J; Winning S
    J Immunol; 2022 Mar; 208(5):1280-1291. PubMed ID: 35121641
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MondoA coordinately regulates skeletal myocyte lipid homeostasis and insulin signaling.
    Ahn B; Soundarapandian MM; Sessions H; Peddibhotla S; Roth GP; Li JL; Sugarman E; Koo A; Malany S; Wang M; Yea K; Brooks J; Leone TC; Han X; Vega RB; Kelly DP
    J Clin Invest; 2016 Sep; 126(9):3567-79. PubMed ID: 27500491
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of TNF-α/TNFR2 in regulatory T cells on the microenvironment and progression of gastric cancer.
    Qu Y; Wang X; Bai S; Niu L; Zhao G; Yao Y; Li B; Li H
    Int J Cancer; 2022 Apr; 150(8):1373-1391. PubMed ID: 34766338
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer.
    Tosolini M; Kirilovsky A; Mlecnik B; Fredriksen T; Mauger S; Bindea G; Berger A; Bruneval P; Fridman WH; Pagès F; Galon J
    Cancer Res; 2011 Feb; 71(4):1263-71. PubMed ID: 21303976
    [TBL] [Abstract][Full Text] [Related]  

  • 56. RORγt Promotes Foxp3 Expression by Antagonizing the Effector Program in Colonic Regulatory T Cells.
    Bhaumik S; Mickael ME; Moran M; Spell M; Basu R
    J Immunol; 2021 Oct; 207(8):2027-2038. PubMed ID: 34518282
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MondoA drives malignancy in B-ALL through enhanced adaptation to metabolic stress.
    Sipol A; Hameister E; Xue B; Hofstetter J; Barenboim M; Öllinger R; Jain G; Prexler C; Rubio RA; Baldauf MC; Franchina DG; Petry A; Schmäh J; Thiel U; Görlach A; Cario G; Brenner D; Richter GHS; Grünewald TGP; Rad R; Wolf E; Ruland J; Sorensen PH; Burdach SEG
    Blood; 2022 Feb; 139(8):1184-1197. PubMed ID: 33908607
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exopolysaccharide-Producing
    Yu R; Zuo F; Ma H; Chen S
    Nutrients; 2019 Apr; 11(4):. PubMed ID: 30987344
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intratumoral depletion of regulatory T cells using CD25-targeted photodynamic therapy in a mouse melanoma model induces antitumoral immune responses.
    Oh DS; Kim H; Oh JE; Jung HE; Lee YS; Park JH; Lee HK
    Oncotarget; 2017 Jul; 8(29):47440-47453. PubMed ID: 28537894
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MicroRNA-124-3p suppresses PD-L1 expression and inhibits tumorigenesis of colorectal cancer cells via modulating STAT3 signaling.
    Roshani Asl E; Rasmi Y; Baradaran B
    J Cell Physiol; 2021 Oct; 236(10):7071-7087. PubMed ID: 33821473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.